V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015728 | 160018001 | 0 | 100.4 | null | null | 2018-02-02 | Capecitabine | 02 | null | CONFIRM TRIAL | 101252207 |
| 160015729 | 160018002 | 1.67 | 88.3 | null | 2018-06-19 | 2018-06-20 | Cyclophosphamide oral | null | null | NOT MATCHED | 101762522 |
| 160015732 | 160018003 | 1.68 | 50 | Curative (C) | 2019-12-29 | 2020-03-08 | EW EuroEwing 2012 Arm A VAC | 01 | null | CISPLATIN + PACLITAXEL | 100872779 |
| 160015739 | 160018004 | 1.6 | 12 | Curative (C) | 2018-08-11 | 2018-09-07 | Doxorubicin + Ifosfamide | 02 | N | GEMCITABINE | 100125940 |
| 160015740 | 160018005 | 1.66 | 104 | Palliative (P) | 2021-07-20 | 2022-01-07 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | N | VAI | 100638111 |
| 160015741 | 160018006 | 1.15 | 73 | 03 | 2019-10-25 | 2019-11-09 | Gemcitabine day 1&8 | 02 | N | RUCAPARIB | 101135079 |
| 160015744 | 160018007 | null | 58 | Palliative (P) | 2018-12-08 | 2019-03-16 | NEMO TRIAL | 01 | N | NOT MATCHED | 101633964 |
| 160015747 | 160018008 | 1.6 | 17.4 | Curative (C) | 2016-11-02 | 2017-04-02 | NB HRNBL | 01 | null | IFOSFAMIDE | 100561282 |
| 160015749 | 160018009 | 1.59 | 12.4 | Adjuvant (A) | 2020-03-04 | 2020-03-04 | CONFIRM TRIAL | 02 | N | IFOSFAMIDE | 101212494 |
| 160015750 | 160018010 | 1.67 | 65.2 | null | 2017-02-26 | 2018-07-28 | Rucaparib | 02 | null | ACALABRUTINIB | 101263802 |
| 160015752 | 160018011 | 1.56 | 103.4 | Curative (C) | 2021-12-19 | 2022-03-31 | null | 01 | N | RADIUM 223 | 101544954 |
| 160015755 | 160018012 | 1.64 | 86.9 | Palliative (P) | 2017-11-06 | 2018-08-24 | Antibody NBL | 02 | N | CAV | 100305949 |
| 160015757 | 160018013 | 1.54 | 46.4 | Palliative (P) | 2019-09-01 | 2019-09-12 | Ifosfamide | N | N | DACTINOMYCIN + CYCLO + VINCRISTINE | 100425329 |
| 160015761 | 160018014 | null | null | null | 2020-04-11 | 2020-07-12 | Bevacizumab+Carbo+Pacliaxel | 02 | null | CISPLATIN + DOXORUBICIN | 100995533 |
| 160015769 | 160018015 | 1.65 | 0 | null | 2018-02-25 | 2018-03-26 | Bortezomib + Daratumumab | null | null | ETOPOSIDE | 101344878 |
| 160015771 | 160018016 | 1.61 | 84.5 | Palliative (P) | 2021-11-29 | 2021-12-02 | Etoposide oral | 02 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 101650294 |
| 160015772 | 160018017 | 1.83 | 10.8 | null | 2017-01-22 | 2017-01-23 | Rituximab | 2 | null | OLAPARIB | 100283352 |
| 160015791 | 160018019 | 1.56 | 84 | Curative (C) | 2019-01-25 | 2019-02-12 | Dinutuximab Beta | 01 | N | EW EUROEWING 2012 ARM B IE | 101717290 |
| 160015794 | 160018020 | 0 | 64.1 | null | 2019-04-02 | 2019-05-20 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100547941 |
| 160015799 | 160018021 | 1.8 | 64.4 | null | 2016-08-05 | 2016-11-26 | Olaparib | 02 | null | CISPLATIN | 100988419 |
| 160015807 | 160018022 | 1.83 | 10.5 | 02 | 2019-10-09 | 2019-10-13 | FLUOROURACIL + OXALIPLATIN | 02 | N | NB HRNBL-1 BUMEL MAT | 100864853 |
| 160015809 | 160018023 | 1.72 | 65.4 | null | 2020-06-01 | 2020-06-01 | CONFIRM TRIAL | 02 | null | CEDIRANIB | 100276551 |
| 160015810 | 160018024 | 0 | 77 | null | 2017-03-17 | 2017-03-17 | CREATE TRIAL | null | null | NOT MATCHED | 101421285 |
| 160015817 | 160018025 | 1.68 | 104 | Curative (C) | 2018-11-06 | 2019-05-02 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | IFOSFAMIDE | 100532897 |
| 160015819 | 160018026 | 0 | 56.15 | Curative (C) | 2019-11-26 | 2019-12-03 | IVADo | 02 | Y | STS RHABDO RMS 2005 VIN CYCLO | 100581305 |
| 160015822 | 160018027 | 1.65 | 93.6 | Palliative (P) | 2019-06-09 | 2019-07-01 | PEMBROLIZUMAB | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100161542 |
| 160015827 | 160018028 | 1.82 | 63 | Curative (C) | 2020-01-17 | 2020-01-23 | null | 02 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100738285 |
| 160015828 | 160018029 | 0 | 76 | Palliative (P) | 2019-07-24 | 2019-07-24 | LORLATINIB | N | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 101299042 |
| 160015829 | 160018030 | 1.6 | 67.6 | null | 2017-01-22 | 2017-02-04 | IVADo | 01 | null | CARBOPLATIN + VINORELBINE | 100658904 |
| 160015832 | 160018031 | 1.43 | 73.8 | null | 2018-09-28 | 2019-08-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | null | CISPLATIN + VINORELBINE | 101427803 |
| 160015833 | 160018032 | 0 | 14.3 | null | 2019-07-18 | 2019-07-23 | EW EuroEwing 99 : VActI | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100956787 |
| 160015847 | 160018033 | 1.62 | 57 | null | 2016-05-27 | 2016-11-12 | EW EuroEwing 2012 Arm B VC | 01 | null | IFOSFAMIDE | 101745278 |
| 160015849 | 160018034 | 1.8 | 96.4 | Palliative (P) | 2021-11-27 | 2022-03-05 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | PEMBROLIZUMAB | 101610665 |
| 160015851 | 160018035 | 1.5 | 113.5 | Curative (C) | 2018-04-16 | 2018-04-16 | Cisplatin + Vinorelbine (PO) | 02 | N | TRIAL | 101470115 |
| 160015859 | 160018036 | 1.73 | 76.8 | null | null | 2016-06-03 | Abiraterone | 02 | null | ATOMIC-MESO TRIAL | 100282020 |
| 160015880 | 160018038 | 0.02 | 56 | null | 2020-12-20 | 2021-05-18 | FLUOROURACIL + IRINOTECAN | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100669712 |
| 160015893 | 160018040 | 1.86 | 52 | null | 2019-10-04 | 2019-10-05 | Doxorubicin + Ifosfamide | null | null | TRIAL | 101637409 |
| 160015898 | 160018041 | 0 | 72.6 | null | 2018-01-25 | 2018-02-19 | Vincristine (weekly) | 02 | null | GEMCITABINE | 100851443 |
| 160015916 | 160018043 | 0 | 74 | Curative (C) | 2017-07-23 | 2017-08-27 | ETOP 13-18 BEAT-meso Trial | 02 | N | OLAPARIB | 101853045 |
| 160015932 | 160018044 | 0 | 16.85 | null | null | 2018-03-21 | EW EuroEwing 2012 Arm B VC | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 101462945 |
| 160015943 | 160018045 | 0 | 15.05 | null | 2021-12-04 | 2021-12-05 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | PEMBROLIZUMAB | 101679938 |
| 160015951 | 160018046 | 1.68 | 58 | null | 2021-05-12 | 2021-05-21 | ETOP 13-18 BEAT-meso Trial | null | null | CYCLOPHOSPHAMIDE | 100041219 |
| 160015952 | 160018047 | 1.65 | null | Curative (C) | 2019-05-11 | 2019-05-11 | Olaparib | 02 | N | GEMCITABINE | 100137761 |
| 160015953 | 160018048 | 1.57 | 70 | Curative (C) | 2016-03-23 | 2016-10-06 | CABOZANTINIB | 02 | N | RUCAPARIB | 100409884 |
| 160015969 | 160018049 | 0 | 60 | null | 2018-08-09 | 2018-08-15 | STS Non-Rhabdo EpSSG 2005 IVA | 02 | null | EW EUROEWING 2012 ARM B IE | 101127652 |
| 160015971 | 160018050 | 1.79 | 91.7 | Curative (C) | 2018-04-18 | 2018-06-07 | IVA | 02 | N | MELPHALAN | 101396540 |
| 160015973 | 160018051 | 0 | 74.7 | Curative (C) | 2019-02-21 | 2019-09-15 | Gemcitabine day 1&8 | 02 | null | NB HRNBL | 100533153 |
| 160015996 | 160018052 | 1.66 | 92.9 | Curative (C) | 2019-11-30 | 2019-12-06 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100967871 |
| 160015998 | 160018053 | 1.56 | 76 | Curative (C) | 2016-01-29 | 2017-02-22 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 02 | null | PEMBROLIZUMAB | 100933905 |
| 160016000 | 160018054 | 1.67 | 66 | null | 2017-05-05 | 2017-05-07 | Docetaxel | 02 | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 101644512 |